Friday, February 23, 2024 |

Rockville company forms scientific advisory board on inflammatory and immunological diseases

January 4, 2024
Vaccine. Hands of a scientist, under a sterile hood, preparing the carcinoembryonic antigen (CEA) vaccinia used to try to prevent cancer. The scientist is diluting the concentrated vaccinnia virus into a dose level appropriate for administration to a patient. This vaccinnia marks any cancer cells expressing the CEA.

AbelZeta Pharma Inc., a global clinical-stage biopharmaceutical company with its U.S. headquarters in Rockville and focused on discovery and development of innovative and proprietary cell-based therapeutic products, announced Wednesday the formation of a scientific advisory board (SAB) to advance its cell therapies for the treatment of inflammatory and immunological diseases.

Article Source: The Daily Record

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.